We co nducted a retrospective study of 29 patients who had undergone stapedectomy for otoselerosis to determin e ho w weil their subjective p erc eptions of hearing improvem ent correlat ed with objecti ve audiom etric m easureme nts. Pati ent s exp ressed their assesstnents of hearing fun ction by comp leting two ve rsions of the Hearing Disability and Handicap Scale (HDHS). One ve rsion of the HDHS wa s based on patient s' retrospecti ve recollections of their hearing impairment prior to surgery, and the oth er reflected the ir assessm ent oftheir current[un ction. We evaluated these HDHS data both separately and in conjunction with preand postoperative audiometricfindings. Following surgery, the group 's mean pure-ton e average improved significantly.fro m 58 to 27dB-that is, the avera ge patient had a moderately severe hearing los s preop eratively and only a mild hearing loss postoperatively. Sign ificant imp rovem ent was also refl ected in the differen ce between the mean p re-andpostop erat ive HDHS scores, although som e patients indi cat ed that they experienced almost no improvetnent . Overall, our findin gs indicated that there was a relationship betw een objective and subjective ass essm ents of hearing improvement followin g surgery, but that it was weak. Although most patient s p erc eiv ed signific ant improvetnent, the degree of that p erceiv ed improvem ent canno t be p redictedfrom the pure-ton e audiog ram. We co ne lude . therefore , that a significant difference between audionietric findin gs and HDHS self-as ses sments is useful in identifying pati ents who might benefit from additional counse ling and/or aural rehabilitation.
Introduction
Stapedectomy for otoselero sis has a high success rate , and surgical and audiologic outcomes are weil described. ' Patients with a moderate to moderately severe conductive hearing loss preoperatively usually improve to the point where their postoperative hearing loss is only mild (air bone gap:~IO dB). 2-5 Customarily, outcomes are measured by the basic audiometric test battery, particularly the pure-tone audiogram. Measurement of the difference in the extent of pre-and postoperative hearing loss and the degree of the elo sure of the air-bone gap provide s an objective means of evalu ating surgical outcomes. However, little is known about the effect of surgery on patients' day-to-day lives . Patients' opinions of their improvement and any residual difficulties are important in determining the success of stapedectomy. Inherently, patients' self-evaluations provide information that is different from but complementary to audiometric data . In fact, studies have shown that patients' self-assessments do not correl ate strongly with audiometric data."?
The World Health Organization distinguishes between hearing disability and hearing handicap , It define s disability as a diminished ability to use hearing in performing everyday tasks, such as understanding speech. It defines handicap as the disadvantage that the disability imposes on the individual patient in the social environment for which the patient cannot compensate phy sically or psychologically, to the detriment of the patient's sense of self-worth and quality of life.8.IO.11 The degr ee of difference between a patient' s hearing impairment and a patient ' s disability and handicap are highly indi vidu al and dependent on behavioral and psychosocial factors.v" Audiometric tests are direet measurements of hearing loss and impairment , Self-reports are indirect assessments designed to gauge typical performance in terms of hearing disability and handicap, " Awareness of the importanc e of hearing disability and handicap led to the development of var ious self-report instruments,14.15 which have been used exten sively in the evalu ation of hearing aids and in auraI rehabilitation." :" How eve r, they have not been included as a measure of surgical outcome.
The addition of a self-evaluation to the custom ary postoperative audiometric test battery has potential benefit s for the patient. The patient with a psychosocial adjustment difficulty could be identified and counseled, For more informa tion Cirele 109 on Reader Service Card Introducing SAVANT' " from (BYON, revolutionary surgieal software that uses MRI and ( AT sean data to produee full-color, 3D perspedive volume renderings of your patient's anatomy. From the perspediveof your surgieal instruments -and in real time during surgery -SAVANT'Mgives you the ability to navigate within a virtually transparent patient.
Never before has the path to your surgieal target been so defined. Frequency (H z)
www.CBVON.com

Results
We tabulated the HDH S respo nses and analyze d them along with eaeh patient' s pre-and postoperative air and bone co nduction results. A udiometric studies. Acco rding to air and bone conduction studies, the ave rage degree of hear ing impairment improve d from moderately severe preoperatively (puretone average [PTA ]: 58 dB) to only mi/ d postoperatively (PTA : 27 dB ; p = 0.0001) (figure I). All surgica l outcomes were co nsidered to be sueeessful (pos toperative air-bo ne gap: <15 dB). These results are typical in terms of both preoperative status and expee ted postoperative outcornes .v-" Total HDHS scores. Preoperative ly, the mea n total HDH S score was 52 .6 (±12 .2). Following surgery, the score improved significantly to 32.7 (±9 .96; p<0.0005) (figure 2). However, it is important to note that the postoperative score did not indiea te the complete absence of any self-perceived disab ilities OI' handicaps; if such were the case , all patients would have had the minim um score of 20.
Subset HDHS scores. Surgery sig nifica ntly improved eac h of the four HDHS subset scores: hearing speec h and Figure 1. Graph illustra tes mean pre-and postoperative puretone airand bone conduction thresholds, along with the standard dev iation fo r air conduction results (p = 0.0001) .
Materials and methods
We identified 39 eonsec utive patient s with otosclerosis who had undergone surgery perform ed by a single surgeon (CA.M.) between 1995 and 1998. Preoperative and one or more pos toperative audiograms were ava ilable on each patie nt.
A ll pa tien ts had un dergo ne th e sma ll fenes tra (stapedotomy) procedure with a hand-held argo n laser device. All patients reeeived a Teflon-pl atinum-wire prosthesis with a diameter of 0.6 mm and a length of 4.25 to 4.50 mm (Ric hards Corp.; Memph is, Tenn .). Preoperatively, all patien ts underwent a Rinne' s test with a 5 12-Hz tuning fork , and in all cases , bone con duetion was better than air co nduction. All proced ures were performed on an outpatient basis. None of these cases was a rev ision surgery , and all patients underwent surge ry on onlyone ear.
We mailed surveys to all 39 patients, and 29 (74%) returned usable responses. Th is grou p consisted of 24 wome n and five men, aged 3 1 to 70 years (mea n: 47). Three patients were retired, five were homemakers, and the remai ning 2 1were active in the work foree . The length of time that had passed since their surgery ranged from 8 weeks to 3 years.
Ineluded in our survey was the Hearing Disability and Handicap Scale (HDHS) developed by Hetu et al." This 20-item ques tio nnaire was developed to measure the severity of the mos t common hearing disabi lities and hearing handi caps in a general adult population.
The HDH S is made up of20 statements, for which there are four possible res ponses : never (I point), seldom (2), often (3), and always (4). Half of the statements concern hearing disabilities, and the other half dea l with hearing handicaps. The state ments on disabilities concern the patient' s ability to hear both speec h (questions 1, 5 , 9, 13, and 17) and nonspeech sounds (questions 2, 6, 10, 14, and 18). The stateme nts on handicaps deal with the patient's sense of self-worth (questions 3, 7, II , 15, and 19) and quality of life (questio ns 4, 8, 12, 16, and 20) . For eac h eircumstance covered by each statement, the absence of difficult y is reflec ted by a score of I and freq uent diffieulty is indicated by a score of 4.
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Call the Cilaxo Wellcome Customer Response Center at 1-888-815-5149 for more infonnation. nonspeech sounds, the two measures of disability, and self-worth and quality of life, the two measures of handicap (p = 0.000 I for all differences) (fig ure 3 ). Despite the fact that the preoperative responses were based on memory and the postoperative responses reflected curre nt status, patien ts clearly indicated that their ability to function auditori ly had improved noticeably.
Hearing disability. Patient s perceived that their ability to hea r speech (mea n pre-and postoperativ e scores for each individual statement: 3.2 and 1.8, respectively) was slightly worse than their ability to hear nonspeech sounds (mea n scores: 3.2 and 1.7). Surgery improve d their ability in both areas substantially, but it did not eliminate all sense of disability. In view of the fact that the average postoperative hearin g loss was only mild, these results co nfirmed the findi ng that patients react differentl y to the imp act of eve n a mild hearing loss."
Hearing handicap. Patients perceived their hearing hand icap to be less acute than their hearing disab ility. The mean sco res for each of the ten statements that deal with hand icap were 2.2 preoperatively and 1.5 postoperatively. Th is finding might be attributable to the fact that the hearin g loss was gra dual and asymmetric.20 In general, patient s had time to adjust slow ly and perhaps more thorou ghl y to their progressive hearing IOSS.21 Furthermore, the onset of hearing loss occurred during their adulthood . When family, social, and professional conditions are stable, adult patient s have the adva ntage of an environm ental support system that can lessen the effects ofhearing IOSS. 21 The loss can there fore be less detrimen-tal to a patient' s sense of self-wo rth and quality ofl ife than might be the case ear lier in life. Even so, not all patient s adapt well to a hearing loss. It has been sugges ted that patient s' pre-hearing-Ioss emotio nal status, coping capabiliti es, and quality of life determ ine how well they adjust." Ten patients (patients 2, 9, 10, 13, 17, 18, 20, 24 , 25, and 27)judged their preoperative hearin g disability and handicap as significa nt, as their HDHS scores added up to 60 and more ( figure 4 ). Postoperatively, there was a general decrease in HDHS scores, but most patients still maintained some perception of disability and/or handicap. Three patients (2, 19 , and 26) had almost no change in their scores, and some others still had relative ly high postoperative HDHS scores. These are the scores that can identify those patients who might benefit from additional counse ling or treatment.
Spearm an' s rank corre lation coefficient with regard to patient s' preoperat ive PTA values and their recoll ect ion of their preoperative status was significant but weak (rho = 0.47; p = 0.0157 ). These data confirmed that pati ent s' perceptions do not correlate highly with audiometric data.?? One reason for this discrepancy might have been the retrospective nature of the rating scale and its reliance on memory. Vario us other factors might have colored our patients' percept ions-factors such as their individual postoperative ex periences, perso nalities, and expectations. Nevertheless, these are factors that are unavoidably part of all patients' judgments of their satisfaction with any procedure. The assumption that the retro- speetive nature of this study might have skewe d patients' pereeptions of their preoperative status was demonstrated by the faet that there was a signifiea ntly better, although stiIl weak, relationship between the postoperative audiometrie and HDHS values (rho = 0.62; P = 0.0034) than there was between the preoperative values. It is elear that patie nts' pereept ions of surgieal outeo mes eannot be predieted by PTA.
The differenee between pre-and postoperative total HDHS seores ranged from 0 to 49 ( figure 5) , and the testretest margin of error was 10. 15 In all, 23 of the 29 patients (79%) said they experieneed a signifiea nt deere ase in iii Travel.
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The Ceraias D 980nm laser is easily portable from office to surgery center. • handic ap, altho ugh perceptions of some disability and handicap remained. Perceptions of disability were more pronounced than perceptions of handicap. Even though surgery was genera lly successful, our patients stiil had a mild hearing loss, which might explain their perception of disabili ty. Regardless of improve ment, some patient s stiil consider even a min imaI hearing imp airment to be a handicap. Th is handi cap might be prevented by famili arizing patient s with the auditory and nonauditory effects of hearing loss so that they might understand how to adjust to their hearing loss and develop techn ique s that can enhance communication.' ?
It weighs only IS Ibs
The HDH S identi fied a few patient s who stiil felt disabled and handicapped; these patie nts were good candidates for co unseling and/or aural reha bilitation. Postoperative management decisions should be based on patients ' perceptions of disa bility and handi cap rather than on pure-tone audiogram alone ."
One pote ntia l draw back of this study is that our patient s judged the outco me of their surgery according to their recall of their preoperative status . However, this is the yard stick all patients use to measure their satisfac tion or dissatisfaction with most forms of treatment for most conditions. It is possible that their recollection was infl uenced by the length of time that had elapsed since surgery , the outcome of their surgery, their perso nality, and other factors. A study to compare patient s' actual preoperative perceptions of their impairment with their subsequent postoperati ve recollections of theircondition might prov e useful for establishing counseling guidelines. . Graph S I IO IVS that the increase in the differ ence betwee n the pre-and postoperat ive HDHS scores corresponds weakly (r = 0.5) with the increase in the difference between the pre-and postop erative PTA (500 to 2,000 Hz). Comparisons are based 011 Pearson 's correlation coefficient.
Discussion
Followin g stapedectomy, our patients experienced a significant reduction in hearing impairment, disability, and hearing disabil ity and handicap and were satisfied with their surgical outcome. Comments on the returned questionnaires illustrated the effec t that stapedectomy had on the perception of heari ng disability and hand icap: "Before having [surgery ], I was frustrated and withdrawn." " It has taken me a while to adjust to sound again. I had forgotte n little sou nds like dripping water or mosqui toes buzzing." "People don 't seem like they are sneaki ng up on me anymore." "I am a better listener now and ofte n ca tch things others miss." These types of co mments confirm that the reve r-saI of hearin g loss had a positiv e impact on daily life. Th e remaining six patient s (1,2,6,8, 19, and 26) did not perceive any decrease in their handicap or disability, desp ite the fact that their surgical and audio logic outcomes were considered to be successful. Th ese are the patients who might benefit from followup co unsel ing or treatment.
In an attempt to determine if PTA can predict how a patient will perceive the outco me of surgery, we plotted the differences between the pre-and postoperative PTAs agai nst the diffe rence in pre-and postoperative perceptions in 27 patients (fig ure  6 ). There was a general trend indicat ing that an increase in the difference between the pre-and postoperative PTA results was accompa nied by a corresponding increase in the difference between the pre-and postoperative HD HS scores. However , the correlatio n was relative ly wea k (r = 0.5). Therefore, we concluded that PTA does not reliably predict how patient s will perceive their surgica l outcome. Although an improve ment in hearing ability generally results in a better percepti on of an alleviation of hearing disability and handicap, this is not the case for all patients. We ca n only spec ulate as to the reason for the poor relatio nship. One of the explana tions offered by Swan and Gatehouse is that perso ns who have high expectations for a full life mig ht be more affec ted by a hearing impairrnent.s But overall, we found that the HDHS accurately indicated that most patients perceived the outcome of their stape dectomy favorably and that it was usefu l in ide ntifying those patients who required add itional co unse ling or rehabi litation serv ices.
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